Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation

Lignende værker

• Experience of NovoSeven administration in management of coagulopathic bleedings after surgical interventions with extracorporeal circulation
  af: Dzybinskaya, E, et al.
  Udgivet: (2006)
• Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
  af: Michalska, G, et al.
  Udgivet: (2007)
• Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery
  af: Niles, Scott D., et al.
  Udgivet: (2008)
• Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
  af: Thabut, D, et al.
  Udgivet: (2004)
• Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
  af: Bonadona, A, et al.
  Udgivet: (2002)